TRIM3 (class VII), meanwhile, upregulates the AKT/PI3K pathway, via an unknown molecular function, thereby dampening ROS, which correlates with a reduction in PD symptoms in a mouse model (Dong et al., 2020). This evidence concerns the gene TRIM3 and Parkinson disease.